306 related articles for article (PubMed ID: 19825996)
1. Phenotypic knockout of CXCR4 by a novel recombinant protein TAT/54R/KDEL inhibits tumors metastasis.
Ma WF; Du J; Fu LP; Fang R; Chen HY; Cai SH
Mol Cancer Res; 2009 Oct; 7(10):1613-21. PubMed ID: 19825996
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic Knockout of CXCR4 Expression by a Novel Intrakine Mutant hSDF-1α/54/KDEL Inhibits Breast Cancer Metastasis.
Chen HY; Clayman ES; Ma WF
J Interferon Cytokine Res; 2015 Oct; 35(10):771-8. PubMed ID: 25978539
[TBL] [Abstract][Full Text] [Related]
3. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.
Zeelenberg IS; Ruuls-Van Stalle L; Roos E
Cancer Res; 2003 Jul; 63(13):3833-9. PubMed ID: 12839981
[TBL] [Abstract][Full Text] [Related]
4. [Construction of intrakine mutant SDF-1alpha/54/KDEL and its inhibiting effects upon CXCR4 expression on cell membrane].
Chen H; Tan Y; Guo Z; Ma W; Cai S; Du J; Huang J; Hu H; Cai S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):647-51, 677. PubMed ID: 18693449
[TBL] [Abstract][Full Text] [Related]
5. Retention of CXCR4 in the endoplasmic reticulum blocks dissemination of a T cell hybridoma.
Zeelenberg IS; Ruuls-Van Stalle L; Roos E
J Clin Invest; 2001 Jul; 108(2):269-77. PubMed ID: 11457880
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells.
Wendt MK; Cooper AN; Dwinell MB
Oncogene; 2008 Feb; 27(10):1461-71. PubMed ID: 17724466
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies.
Vaday GG; Hua SB; Peehl DM; Pauling MH; Lin YH; Zhu L; Lawrence DM; Foda HD; Zucker S
Clin Cancer Res; 2004 Aug; 10(16):5630-9. PubMed ID: 15328206
[TBL] [Abstract][Full Text] [Related]
9. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells.
Sung B; Jhurani S; Ahn KS; Mastuo Y; Yi T; Guha S; Liu M; Aggarwal BB
Cancer Res; 2008 Nov; 68(21):8938-44. PubMed ID: 18974138
[TBL] [Abstract][Full Text] [Related]
10. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
Hu J; Deng X; Bian X; Li G; Tong Y; Li Y; Wang Q; Xin R; He X; Zhou G; Xie P; Li Y; Wang JM; Cao Y
Clin Cancer Res; 2005 Jul; 11(13):4658-65. PubMed ID: 16000558
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
[TBL] [Abstract][Full Text] [Related]
12. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
Li F; Zhu HS; Han ZQ; Chen G; Gao QL; Jia P; Zhang AL; Xi L; Xu Q; Liao GN; Wang SX; Lu YP; Ma D
Ai Zheng; 2005 Jan; 24(1):23-7. PubMed ID: 15642195
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells.
Jones J; Marian D; Weich E; Engl T; Wedel S; Relja B; Jonas D; Blaheta RA
Exp Cell Res; 2007 Nov; 313(19):4051-65. PubMed ID: 17706641
[TBL] [Abstract][Full Text] [Related]
14. A novel recombinant protein TAT-GFP-KDEL with dual-function of penetrating cell membrane and locating at endoplasm reticulum.
Ma WF; Chen HY; Du J; Tan Y; Cai SH
J Drug Target; 2009 May; 17(4):329-33. PubMed ID: 19558358
[TBL] [Abstract][Full Text] [Related]
15. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells.
Schabath H; Runz S; Joumaa S; Altevogt P
J Cell Sci; 2006 Jan; 119(Pt 2):314-25. PubMed ID: 16390867
[TBL] [Abstract][Full Text] [Related]
16. A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer.
Huang EH; Singh B; Cristofanilli M; Gelovani J; Wei C; Vincent L; Cook KR; Lucci A
J Surg Res; 2009 Aug; 155(2):231-6. PubMed ID: 19482312
[TBL] [Abstract][Full Text] [Related]
17. Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells.
Holland JD; Kochetkova M; Akekawatchai C; Dottore M; Lopez A; McColl SR
Cancer Res; 2006 Apr; 66(8):4117-24. PubMed ID: 16618732
[TBL] [Abstract][Full Text] [Related]
18. HIV-1-Tat potentiates CXCL12/stromal cell-derived factor 1-induced downregulation of membrane CXCR4 in T lymphocytes through protein kinase C zeta.
Hidalgo-Estévez AM; Punzón C; Sanchez-Duffhues G; Muñoz E; Fresno M
Mol Immunol; 2008 Nov; 46(1):106-15. PubMed ID: 18760839
[TBL] [Abstract][Full Text] [Related]
19. Loss of C-terminal alpha-helix decreased SDF-1alpha-mediated signaling and chemotaxis without influencing CXCR4 internalization.
Cai SH; Tan Y; Ren XD; Li XH; Cai SX; Du J
Acta Pharmacol Sin; 2004 Feb; 25(2):152-60. PubMed ID: 14769202
[TBL] [Abstract][Full Text] [Related]
20. Intrakines--evidence for a trans-cellular mechanism of action.
Engel BC; Bauer G; Pepper KA; Bockstoce DC; Yu XJ; Chen SY; Kohn DB
Mol Ther; 2000 Feb; 1(2):165-70. PubMed ID: 10933927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
